Effect of lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 1, 2001, Pages 11-17

  Gotteland, M ^a   Cruchet, S ^a   Verbeke, S ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MUCOSA; HUMAN; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; GASTRIC MUCOSA; HUMANS; INDOMETHACIN; LACTOBACILLUS; MALE; PERMEABILITY;

EID: 0035182040     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00898.x     Document Type: Article

References (36)

1. Epidemiological evidence on the association between peptic ulceration and anti-inflammatory drugs
2. Gastroscopic findings after therapy with nonsteroidal anti-inflammatory drugs
3. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine
4. The biochemical basis of nonsteroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: A review and an hypothesis
5. Intestinal permeability and inflammation in patients on NSAIDs
6. Toxicokinetics of indomethacin-induced intestinal permeability in the rat
7. Effects of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine
8. Small intestinal ulcers and intestinal flora in rats given indomethacin
9. Nonsteroidal anti-inflammatory drugs enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation
10. Role of bacteria in gastric ulceration produced by indomethacin in the rat: Cytoprotective action of antibiotics
11. Bacteria rapidly colonize and modulate healing of gastric ulcers in rats
12. Clinical applications of probiotic bacteria
13. Probiotics
14. Probiotics in human medicine
15. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
16. Lactobacillus casei sp strain GG reverses increased intestinal permeability induced by cow's milk in suckling rats
17. Effect of acute smoking on gastric permeability to sucrose in healthy volunteers
18. Estimation of disaccharides in plasma and urine by gas-liquid chromatography
19. Sucrose: A novel permeability marker for gastroduodenal disease
20. Noninvasive detection of nonsteroidal anti-inflamatory drug-induced gastropathy in dog
21. Effects of aspirin and Helicobacter pylori on the gastroduodenal disease
22. Sucrose permeability in children with gastric damage and Helicobacter pylori infection
23. Enterocyte mitochondrial damage due to NSAID in the rat
24. Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti-inflamatory drug
25. Luminal bacteria and small-intestinal permeability
26. Small intestinal bacterial overgrowth and enhanced intestinal permeability in healthy beagles
27. Probiotics reinforce mucosal degradation of antigens in rats: Implications for therapeutic use of probiotics
28. Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and futures challenges
29. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression
30. Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD
31. Protective effects of a culture supernatant of Lactobacillus acidophilus and antioxidants on ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug
32. Culture supernatants of Lactobacillus acidophilus and Bifidobacterium adolescentis repress ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug by suppressing unbalanced growth of aerobic bacteria and lipid peroxidation
33. Antioxidative properties of Lactobacillus GG
34. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model
35. Effect of whey-based culture supernatant of Lactobacillus acidophillus (johnsonii) La1 on Helicobacter pylori infection in humans